Bertil Christensson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bertil Christensson has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
G. Sigmundsdottir
Department of Infectious Diseases and Medical Microbiology, Lund University Hospital, Lund, Sweden
2 shared publicationsL. Larsson
Department of Infectious Diseases and Medical Microbiology, Lund University Hospital, Lund, Sweden
2 shared publicationsAdam Linder
From the Department of Medical Microbiology, Dermatology and Infection, Division of Infectious Diseases, Lund University Hospital, SE-221 85, Lund, Sweden
1 shared publicationAnders Widell
Department of Medical Microbiology, University Hospital, Malmö, Sweden
1 shared publicationAnn Åkesson
Department of Infectious Diseases, University Hospital, Lund, Sweden
1 shared publication- Björn Petrini
Department of Clinical Microbiology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
1 shared publication
Latest Publications
- 18 July 2008
- Published by Wiley in Medical Mycology
- Vol. 37 (6) , 391-396
D-arabinitol - a marker for invasive candidiasis
- 18 July 2008
- Published by Wiley in Medical Mycology
- Vol. 37 (6) , 391-396
D-arabinitol - a marker for invasive candidiasis
- 1 January 2004
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 36 (1) , 63-64
Group A streptococcus bacteraemia complicated by osteomyelitis in an immunocompetent adult.
Osteomyelitis due to group A streptococcus is an unusual complication of varicellae in children. We report the first case of group A streptococcus bacteraemia complicated by multifocal osteomyelitis in an adult.
- 1 January 2004
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 36 (1) , 63-64
Group A streptococcus bacteraemia complicated by osteomyelitis in an immunocompetent adult.
Osteomyelitis due to group A streptococcus is an unusual complication of varicellae in children. We report the first case of group A streptococcus bacteraemia complicated by multifocal osteomyelitis in an adult.
- 1 August 2000
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 38 (8) , 3039-3042
Urine d -Arabinitol/ l -Arabinitol Ratio in Diagnosis of Invasive Candidiasis in Newborn Infants
Infants treated in neonatal intensive care units suffer an increased risk for invasive candidiasis, but the diagnosis is sometimes difficult. d -arabinitol is a metabolite of most pathogenic Candida species. An elevated urine d -arabinitol/ l -arabinitol (DA/LA) ratio is a sensitive sign of invasive candidiasis in children with cancer, but the method has not been previously evaluated for newborn infants. We therefore enrolled 117 infants in a neonatal intensive care unit, and 411 urine samples were obtained on filter paper. The DA/LA ratio was measured by gas chromatography-mass spectrometry. For 81 infants with no suspicion of superficial or invasive candidiasis, the urine DA/LA ratio was 2.7 ± 0.7 (mean ± standard deviation [SD]). The upper cutoff level was set at 4.8 (mean plus 3 SD). Of 22 infants with mucocutaneous candidiasis and not given systemic antifungal treatment, two had elevated DA/LA ratios, which normalized after removal of intravascular catheters. Eight other infants were given empiric antifungal treatment but had negative cultures; five of these had repeatedly elevated DA/LA ratios. Six infants with culture-positive invasive candidiasis all had one or more samples with elevated ratios. For seven infants, three with suspected and four with confirmed invasive candidiasis (for which follow-up samples were available), ratios normalized during antifungal treatment. In conclusion, urine DA/LA ratio determination is a rapid test and can be used for newborns. It is possibly more sensitive than fungal blood cultures in the diagnosis of invasive candidiasis and can also be used for monitoring the effect of antifungal treatment.
- 1 August 2000
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 38 (8) , 3039-3042
Urine d -Arabinitol/ l -Arabinitol Ratio in Diagnosis of Invasive Candidiasis in Newborn Infants
Infants treated in neonatal intensive care units suffer an increased risk for invasive candidiasis, but the diagnosis is sometimes difficult. d -arabinitol is a metabolite of most pathogenic Candida species. An elevated urine d -arabinitol/ l -arabinitol (DA/LA) ratio is a sensitive sign of invasive candidiasis in children with cancer, but the method has not been previously evaluated for newborn infants. We therefore enrolled 117 infants in a neonatal intensive care unit, and 411 urine samples were obtained on filter paper. The DA/LA ratio was measured by gas chromatography-mass spectrometry. For 81 infants with no suspicion of superficial or invasive candidiasis, the urine DA/LA ratio was 2.7 ± 0.7 (mean ± standard deviation [SD]). The upper cutoff level was set at 4.8 (mean plus 3 SD). Of 22 infants with mucocutaneous candidiasis and not given systemic antifungal treatment, two had elevated DA/LA ratios, which normalized after removal of intravascular catheters. Eight other infants were given empiric antifungal treatment but had negative cultures; five of these had repeatedly elevated DA/LA ratios. Six infants with culture-positive invasive candidiasis all had one or more samples with elevated ratios. For seven infants, three with suspected and four with confirmed invasive candidiasis (for which follow-up samples were available), ratios normalized during antifungal treatment. In conclusion, urine DA/LA ratio determination is a rapid test and can be used for newborns. It is possibly more sensitive than fungal blood cultures in the diagnosis of invasive candidiasis and can also be used for monitoring the effect of antifungal treatment.
- Open Access
- 1 March 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (3) , 585-586
Interferon- and Ribavirin Treatment of Hepatitis C in Children with Malignancy in Remission
Twenty-eight cases of hepatitis C virus (HCV) infection were identified in children in a pediatric oncology ward during 2 nosocomial outbreaks. HCV i
- 1 March 2000
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (3) , 585-586
Open AccessInterferon- and Ribavirin Treatment of Hepatitis C in Children with Malignancy in Remission
Twenty-eight cases of hepatitis C virus (HCV) infection were identified in children in a pediatric oncology ward during 2 nosocomial outbreaks. HCV i
- Open Access
- 1 December 1999
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 37 (6) , 391-396
D-arabinitol - a marker for invasive candidiasis
B. Christensson, G. Sigmundsdottir, L. Larsson; D-arabinitol — a marker for invasive candidiasis, Medical Mycology, Volume 37, Issue 6, 1 January 1999, Pages 3
- 1 December 1999
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 37 (6) , 391-396
Open AccessD-arabinitol - a marker for invasive candidiasis
B. Christensson, G. Sigmundsdottir, L. Larsson; D-arabinitol — a marker for invasive candidiasis, Medical Mycology, Volume 37, Issue 6, 1 January 1999, Pages 3
- 18 February 1998
- Vol. 95 (8) , 738-42
[Advances in the diagnosis of mycoses. New tests detect Candida infections].
New techniques for the detection of deep fungal infections are reviewed with a focus on Candida albicans, the species most frequently isolated. The introduction provides an outline of the similarities and differences between bacteria and fungi on one hand and animal cells on the other, which are important to bear in mind in the detection and treatment of deep fungal infections. In addition to cultures of biopsy material, blood, and mucous membranes (colonisation), serum tests for such fungal constituents as antigens or beta-glucan, the PCR technique for the detection of fungal DNA, and a test for the D-/L-arabinitol ratio in urine, are all valuable approaches. As yet, no single laboratory test is available that reliably detects disseminated candidosis. Rapid, sensitive, and specific methods for mycological diagnosis need to be developed to minimize the necessity of resorting to empirical therapy when deep mycosis is suspected.
- 18 February 1998
- Vol. 95 (8) , 738-42
[Advances in the diagnosis of mycoses. New tests detect Candida infections].
New techniques for the detection of deep fungal infections are reviewed with a focus on Candida albicans, the species most frequently isolated. The introduction provides an outline of the similarities and differences between bacteria and fungi on one hand and animal cells on the other, which are important to bear in mind in the detection and treatment of deep fungal infections. In addition to cultures of biopsy material, blood, and mucous membranes (colonisation), serum tests for such fungal constituents as antigens or beta-glucan, the PCR technique for the detection of fungal DNA, and a test for the D-/L-arabinitol ratio in urine, are all valuable approaches. As yet, no single laboratory test is available that reliably detects disseminated candidosis. Rapid, sensitive, and specific methods for mycological diagnosis need to be developed to minimize the necessity of resorting to empirical therapy when deep mycosis is suspected.